Cite
HARVARD Citation
Savarirayan, R. et al. (2022). Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies. Therapeutic advances in musculoskeletal disease. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Savarirayan, R. et al. (2022). Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies. Therapeutic advances in musculoskeletal disease. p. . [Online].